Across TCGA pan-cancer cohorts, ARHGAP27P1-BPTFP1-KPNA2P3 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated ARHGAP27P1-BPTFP1-KPNA2P3 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ARHGAP27P1-BPTFP1-KPNA2P3 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ARHGAP27P1-BPTFP1-KPNA2P3 expression acts as an unfavorable survival marker.

BLCA, KIRC, and COAD are the cancer types where ARHGAP27P1-BPTFP1-KPNA2P3 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.052	0.688	<.001	30	view →
KIRC	OS	Median	All	0.266	0.805	.017	12	view →
COAD	OS	Median	All	0.168	0.799	.014	9	view →
LUAD	OS	Median	III,IV	0.223	0.677	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: ARHGAP27P1-BPTFP1-KPNA2P3 tumor-vs-normal RNA expression · all ARHGAP27P1-BPTFP1-KPNA2P3 data types